Related Experiment Videos
[Congenital muscular dystrophy. Apropos of 4 cases]
I J Posada1, J A Molina, C Ramo
1Servicio de Neurolog'ia, Hospital l de Octubre, Madrid.
Insights
Congenital muscular dystrophy presents with early-onset weakness and hypotonia. High creatine kinase (CK) levels and specific muscle biopsy findings aid in early diagnosis of this condition.
Area of Science:
- Neurology
- Pediatrics
- Genetics
Background:
- Congenital muscular dystrophy (CMD) is a group of inherited disorders characterized by muscle weakness present at birth.
- Early diagnosis is crucial for managing the condition and providing supportive care.
Observation:
- This report details four cases of congenital muscular dystrophy with varying clinical severity.
- Symptoms included congenital hypotonia and muscular weakness, with onset from birth or early infancy.
- Joint contractures were observed in three patients, and one case resulted in mortality due to respiratory infection.
Findings:
- All patients exhibited significantly elevated serum creatine kinase (CK) levels.
- Muscle biopsies revealed pathological changes indicative of muscular dystrophy, including endomysial and perimysial fibrosis and fatty infiltration.
Implications:
- The study highlights the importance of clinical presentation and biochemical markers, particularly serum CK levels, in suspecting early diagnosis of congenital muscular dystrophy.
- Recognizing these indicators can facilitate timely intervention and genetic counseling for affected families.
Abstract:
Four cases of congenital muscular dystrophy are reported. Muscular weakness and hypotonia, with different clinical severity, was present from birth in three patients; in the fourth one, it began at two months old. Three cases had joint contractures. One patient died by respiratory infection. Serum CK level was very high in all of them. Muscle biopsies showed pathologic changes consistent with muscular dystrophy with endomysial and perimysial fibrosis and fatty infiltration. Authors analysed this illness emphasizing clinical and biochemical (CK) data so that an early diagnosis can be suspected.